Investing14d
Vertex Pharmaceuticals' SWOT analysis: cystic fibrosis leader faces pipeline challenges
While CF remains Vertex's primary revenue driver, the company is actively working to diversify its portfolio. Several key pipeline programs and potential product launches are on the horizon: 1.
Investing14d
Vertex Pharmaceuticals' SWOT analysis: cystic fibrosis leader faces pipeline challenges
While CF remains Vertex's primary revenue driver, the company is actively working to diversify its portfolio. Several key pipeline programs and potential product launches are on the horizon ...
KTHV14d
FDA approves Journavx, the first new painkiller in over two decades
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally ...
PBS14d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioids
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally ...
Cleveland.com14d
FDA approves new painkiller designed to avoid opioid addiction risk
Vertex has attracted interest from Wall Street for its ambitious drug pipeline that involves winning FDA approval for multiple drugs across several forms of chronic pain, which generally ...